Molbio Diagnostics Sets IPO Price Band Between 768 and 807 Rupees per Share

Molbio Diagnostics Limited has officially set the price band for its upcoming Initial Public Offering (IPO) at ₹768 to ₹807 per share. According to the company's newspaper advertisements and regulatory filings published on August 5, 2026, the public subscription window will run from August 10, 2026, to August 12, 2026. The launch marks a significant capital-raising event for India's healthcare and diagnostic device sector, bringing the high-growth molecular diagnostics manufacturer to the domestic equity markets.

IPO Structure and Capital Allocation

The total size of the book-building issue stands at ₹939.85 crore. The issue comprises:

• Fresh Issue: 0.25 crore shares aggregating up to ₹200.16 crore.

• Offer for Sale (OFS): 0.92 crore shares aggregating up to ₹739.70 crore, offered by existing shareholders.

At the upper price band of ₹807 per share, Molbio Diagnostics achieves an estimated post-issue market capitalization of ₹9,299.87 crore. The face value of each equity share is ₹1.

Timeline and Key Investment Details

Retail investors can apply for a minimum lot size of 18 equity shares, requiring a minimum investment of ₹14,526 at the upper cap.

• Subscription Period: August 10, 2026 – August 12, 2026

• Basis of Allotment Finalization: August 13, 2026

• Tentative Listing Date: August 17, 2026

• Trading Venues:
  BSE Limited
  and the
  National Stock Exchange of India (NSE)
  .

Kotak Mahindra Capital Company Limited is acting as the lead manager for the offer, while KFin Technologies Limited has been appointed as the registrar.

Official Sources Section

Details regarding the price band, offer structure, and key dates were confirmed via official public disclosures, statutory newspaper advertisements, and the Red Herring Prospectus (RHP) filed with market regulators.

Quote Section

According to company filings and statutory releases, the fresh capital will be directed toward scaling operational infrastructure and expansion initiatives outlined in the RHP.

Why It Matters

The listing provides retail and institutional market participants an entry into the medical diagnostics technology sector. With point-of-care PCR testing systems seeing sustained demand across global healthcare networks, the capital raised from the fresh issue will bolster domestic manufacturing capacity and expansion programs.

Key Facts at a Glance

• Price Band: ₹768 to ₹807 per equity share

• Total Issue Size: ₹939.85 crore (Fresh: ₹200.16 Cr; OFS: ₹739.70 Cr)

• Lot Size: 18 Shares (Minimum Retail Outlay: ₹14,526)

• Issue Dates: August 10 to August 12, 2026

• Expected Listing Date: August 17, 2026 (BSE & NSE)

FAQ Section

What is the price band for the Molbio Diagnostics IPO?

The price band has been fixed between ₹768 and ₹807 per share.

When does the Molbio Diagnostics IPO open and close?

The issue opens for subscription on August 10, 2026, and closes on August 12, 2026.

What is the minimum investment required for retail investors?

Retail investors must bid for at least one lot of 18 shares, which amounts to ₹14,526 at the upper price band of ₹807.

On which exchanges will Molbio Diagnostics be listed?

The shares will be listed on both BSE and NSE.

Featured Image Recommendation:

A high-resolution photo of molecular diagnostic equipment or laboratory point-of-care testing machinery in a modern medical laboratory, with market ticker screens overlaying the background.

Source: BSE India, National Stock Exchange of India, Chittorgarh IPO Desk.